JPRN-UMIN000000464已完成1 期
Phase 1/2 study of the combination of nedaplatin and ifosfamide in patients with advanced or recurrent cervical cancer - Phase 1/2 study of the combination of nedaplatin and ifosfamide in patients with advanced or recurrent cervical cancer
Graduate School of Medicine, Chiba University0 个研究点目标入组 25 人开始时间: 2006年8月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Severe complications: a) infections, diarrhea (watery), ileus, interstistial pneumonitis, lung fibrosis, b) massive pleural effusion or ascites, c) uncontrollable diabetes mellitus, d) other complications which suffer from progressing study. 2) Co-existence of active other malignancies. 3) Whom the investigator think unappropriate as a candidate.
研究者
相似试验
招募中
1 期
Phase I/II trial of Nedaplatin/S-1 combination followed by maintenance S-1 therapy in advanced Squamous Cell Lung CancerJPRN-UMIN000009399Department of Medical Oncology, Kinki University Faculty of Medicine25
已完成
2 期
Phase II study of nedaplatin for advanced or relapsed squamous cell lung cancer in chemo-naive elderly patientssquamous cell lung cancerJPRN-UMIN000007054Shizuoka Cancer Center25
已完成
3 期
Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lungsquamous cell carcinoma of the lungJPRN-UMIN000002015West Japan Oncology Group350
已完成
1 期
A phase I trial of weekly Nedaplatin and concurrent thoracic radiotherapy for elderly patients with locally advanced squamous cell lung cancerJPRN-UMIN000021226Osaka medical college hospital18
招募中
2 期
Phase II Study of Nedaplatin+TS-1 for previously untreated patients with squamous cell lung cancerSquamous cell lung cancerJPRN-UMIN000009550Toho university25